Substances that attract eosinophils in vitro and in vivo, and that elicit blood eosinophilia.
D000707:Anaphylaxis / Q000276:immunology; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001491:Basophils / Q000502:physiology; D004802:Eosinophilia / Q000139:chemically induced* / Q000188:drug therapy; D004804:Eosinophils / Q000187:drug effects* / Q000276:immunology; D006168:Guinea Pigs; D000882:Haplorhini; D006632:Histamine / Q000494:pharmacology*; D007073:Immunoglobulin E; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D008168:Lung / Q000276:immunology; D008198:Lymph Nodes / Q000503:physiopathology; D008407:Mast Cells / Q000276:immunology; D009504:Neutrophils / Q000187:drug effects*; D010323:Passive Cutaneous Anaphylaxis; D011691:Puromycin / Q000627:therapeutic use; D012867:Skin / Q000276:immunology
D000961:Antilymphocyte Serum; D007074:Immunoglobulin G; D007073:Immunoglobulin E; D011691:Puromycin; D006632:Histamine